ICDX — Incordex Income Statement
0.000.00%
Last trade - 00:00- $8.39m
- $8.39m
- $0.01m
Annual income statement for Incordex, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Revenue | ||||
| Total Revenue | 0 | 0.005 | 0.005 | 0.01 |
| Selling / General / Administrative Expenses | ||||
| Total Operating Expenses | 0.001 | 0.013 | 0.02 | 0.018 |
| Operating Profit | -0.001 | -0.008 | -0.015 | -0.009 |
| Net Income Before Taxes | -0.001 | -0.008 | -0.015 | -0.009 |
| Provision for Income Taxes | ||||
| Net Income After Taxes | -0.001 | -0.008 | -0.015 | -0.009 |
| Net Income Before Extraordinary Items | ||||
| Net Income | -0.001 | -0.008 | -0.015 | -0.009 |
| Income Available to Common Shareholders Excluding Extraordinary Items | ||||
| Income Available to Common Shareholders Including Extraordinary Items | ||||
| Diluted Net Income | -0.001 | -0.008 | -0.015 | -0.009 |
| Diluted Weighted Average Shares | ||||
| Basic EPS Including Extraordinary Items | ||||
| Diluted EPS Including Extraordinary Items | ||||
| Diluted EPS Excluding Extraordinary Items | ||||
| Normalised Income Before Taxes | ||||
| Normalised Income After Taxes | ||||
| Normalised Income Available to Common Shareholders | ||||
| Diluted Normalised EPS | -0 | -0.002 | -0.002 | -0.001 |
| Dividends per Share |